
The Shock Index Creatinine (SIC) scoring, a recent risk stratification tool used in ST-Elevation Myocardial Infarction (STEMI), lacks evaluation for predicting outcomes in Acute Coronary Syndrome (ACS) patients. This retrospective single-centre study, conducted from January 2018 to January 2022, enrolled 1349 ACS patients aged ≥ 18 years, analyzing SIC scores in relation to in-hospital mortality. Multivariate analysis revealed a significant association, with SIC ≥ 25 showing higher in-hospital mortality (p < 0.001, odds ratio 2.655). The Receiver Operating Characteristics curve demonstrated acceptable predictive value (AUC = 0.789, 95% CI: 0.748–0.831, p < 0.001), making SIC a valuable predictor, especially with a score ≥ 25, across all ACS spectrums. This study pioneers comprehensive SIC evaluation in ACS.
Like
Save
Share